Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders
- PMID: 38315384
- DOI: 10.1007/s11899-024-00724-z
Pulmonary, Hepatic, and Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Telomere Biology Disorders
Abstract
Purpose of the review: This study aimed to summarize evidence and provide consensus-based guidelines for management of transplantation in patients with telomere biology disorders (TBD). Specifically, this review focuses on clinical management of lung, liver, and bone marrow transplantation in TBD patients.
Recent findings: TBD patients have specific unique biological vulnerabilities such as T cell immunodeficiency, susceptibility to infections, hypersensitivity to chemotherapy and radiation, and cytopenias. Furthermore, multiple organ involvement at diagnosis makes clinical management especially challenging due to higher degree of organ damage, and stress-induced telomeric crisis. Sequential and combined organ transplants, development of novel radiation and alkylator-free conditioning regimen, and use of novel drugs for graft-versus-host disease prophylaxis are some of the recent updates in the field. Multidisciplinary management is essential to optimize transplant outcomes in patients with TBD. In this review, we provide consensus-based transplant management guidelines for clinical management of transplant in TBD.
Keywords: Bone marrow transplant; Liver transplant; Lung transplant; TBD; Telomere biology disorders; Transplantation.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Similar articles
-
Hematopoietic cell transplantation for telomere biology diseases: A retrospective single-center cohort study.Eur J Haematol. 2023 Sep;111(3):423-431. doi: 10.1111/ejh.14023. Epub 2023 Jun 1. Eur J Haematol. 2023. PMID: 37259830
-
Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease.Respir Med. 2023 Dec;220:107464. doi: 10.1016/j.rmed.2023.107464. Epub 2023 Nov 10. Respir Med. 2023. PMID: 37951311
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience.J Egypt Natl Canc Inst. 2020 Feb 22;32(1):11. doi: 10.1186/s43046-020-0020-1. J Egypt Natl Canc Inst. 2020. PMID: 32372257
-
Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.Biol Blood Marrow Transplant. 2017 Mar;23(3):379-387. doi: 10.1016/j.bbmt.2016.12.619. Epub 2017 Jan 6. Biol Blood Marrow Transplant. 2017. PMID: 28068510 Free PMC article. Review.
Cited by
-
Genetic predisposition to myelodysplastic syndrome: Genetic counseling and transplant implications.Semin Hematol. 2024 Dec;61(6):370-378. doi: 10.1053/j.seminhematol.2024.09.003. Epub 2024 Sep 22. Semin Hematol. 2024. PMID: 39443230 Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials